Skip to content

Study · Measured the body's own peptide · 2002

1 result

Monitoring changes in gene expression in renal ischemia-reperfusion in the rat.

Yoshida T, Kurella M, Beato F, Min H, Ingelfinger JR, Stears RL, Swinford RD, Gullans SR, Tang SS

Kidney international1 May 2002Cited by 108 (Europe PMC)

PMID11967014 (opens in a new tab)DOI10.1046/j.1523-1755.2002.00341.x (opens in a new tab)PepBankPUB-11967014
Source linkPubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelAnimal study (in vivo)Mechanism

    In rats with renal ischemia-reperfusion, microarray analysis showed thymosin beta4 expression was up-regulated in the early phase.

    In plain wordsIn rats with kidney ischemia-reperfusion, the body's own thymosin beta4 gene was more active early after injury.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    IncreaseRenal thymosin beta4 expression in early phase
    Study

    ratn: not reported in source

    Bilateral renal ischemia-reperfusion
    Outcome group
    Gene expression · Kidney and urinary

    Source sentences

    Summary
    Nine genes were up-regulated (ADAM2, HO-1, UCP-2, and thymosin beta4 in the early phase
    1 context sentence
    Summary · context
    Male Wistar rats underwent bilateral renal ischemia (30 min) or sham operation, followed by reperfusion for 1, 2, 3 or 4 days.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.